• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Oxidized phospholipids inhibit the formation of cholesterol-dependent plasma membrane nanoplatforms
 
  • Details
  • Full
Options
2016
Journal Article
Title

Oxidized phospholipids inhibit the formation of cholesterol-dependent plasma membrane nanoplatforms

Abstract
We previously developed a single-molecule microscopy method termed TOCCSL (thinning out clusters while conserving stoichiometry of labeling), which allows for direct imaging of stable nanoscopic platforms with raft-like properties diffusing in the plasma membrane. As a consensus raft marker, we chose monomeric GFP linked via a glycosylphosphatidylinositol (GPI) anchor to the cell membrane (mGFP-GPI). With this probe, we previously observed cholesterol-dependent homo-association to nanoplatforms diffusing in the plasma membrane of live CHO cells. Here, we report the release of this homo-association upon addition of 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC) or 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine, two oxidized phospholipids (oxPLs) that are typically present in oxidatively modified low-density lipoprotein. We found a dose-response relationship for mGFP-GPI nanoplatform disintegration upon addition of POVPC, correlating with the signal of the apoptosis marker Annexin V-Cy3. Similar concentrations of lysolipid showed no effect, indicating that the observed phenomena were not linked to properties of the lipid bilayer itself. Inhibition of acid sphingomyelinase by NB-19 before addition of POVPC completely abolished nanoplatform disintegration by oxPLs. In conclusion, we were able to determine how oxidized lipid species disrupt mGFP-GPI nanoplatforms in the plasma membrane. Our results favor an indirect mechanism involving acid sphingomyelinase activity rather than a direct interaction of oxPLs with nanoplatform constituents.
Author(s)
Brameshuber, Mario
TU Wien
Sevcsik, Eva
TU Wien
Rossboth, Benedikt K.
TU Wien
Manner, Christina
TU Wien
Deigner, Hans-Peter
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Peksel, Begüm
Hungarian Academy of Sciences, Szeged
Péter, Mária
Hungarian Academy of Sciences, Szeged
Török, Zsolt
Hungarian Academy of Sciences, Szeged
Hermetter, Albin
TU Graz
Schütz, Gerhard J.
TU Wien
Journal
Biophysical journal  
DOI
10.1016/j.bpj.2015.11.018
Additional link
Full text
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024